This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Paradigm Therapeutics Ltd. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Graham Andrew Showell: Innovator in Silicon Compounds
Introduction
Graham Andrew Showell is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of materials science, particularly in the development of silicon compounds. With a keen focus on innovation, he has been able to secure a patent that showcases his expertise and creativity.
Latest Patents
Graham holds one patent titled "Silicon compounds and their use." This patent encompasses innovative compounds represented by formulas I and II, with specific variables defined in the accompanying claims. The application of these silicon compounds has the potential for various uses, which may significantly impact multiple industries.
Career Highlights
Graham Andrew Showell works at Paradigm Therapeutics Ltd., a company dedicated to advancing therapeutic innovations. His role at Paradigm is indicative of his commitment to pushing the boundaries of scientific research and development. With only one patent to his name so far, his work continues to garner attention as he explores new frontiers in silicon chemistry.
Collaborations
Throughout his career, Graham has collaborated with talented professionals, including colleagues David Miller and Parminder Kaur Ruprah. These partnerships not only enhance the research environment at Paradigm Therapeutics but also foster innovative ideas that can lead to further breakthroughs in their respective fields.
Conclusion
Graham Andrew Showell stands out as an inventive force in the development of silicon compounds. His patent represents a crucial step toward advancing materials science and therapeutic applications. With ongoing collaborations and a dedicated presence at Paradigm Therapeutics, the future looks promising for Graham and his contributions to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile